Short answer · Medically reviewed summary · Last updated: 2026-04-07
Familial Mediterranean Fever (FMF) is a rare autoinflammatory disorder with a highly variable prevalence that is most common among populations of Mediterranean, Middle Eastern, and North African descent. While exact global figures are difficult to determine due to frequent underdiagnosis, studies suggest a prevalence ranging from 1 in 200 to 1 in 1,000 in high-risk populations, with the majority of patients experiencing their first symptoms before the age of 20. What is the estimated prevalence and incidence of Familial Mediterranean Fever? The prevalence of Familial Mediterranean Fever varies significantly based on geography and ethnicity.
Familial Mediterranean Fever (FMF) is a rare autoinflammatory disorder with a highly variable prevalence that is most common among populations of Mediterranean, Middle Eastern, and North African descent. While exact global figures are difficult to determine due to frequent underdiagnosis, studies suggest a prevalence ranging from 1 in 200 to 1 in 1,000 in high-risk populations, with the majority of patients experiencing their first symptoms before the age of 20.
The prevalence of Familial Mediterranean Fever varies significantly based on geography and ethnicity. In populations with high ancestral risk—including Sephardic and Ashkenazi Jews, Armenians, Turks, and Arabs—the prevalence is estimated between 1 in 200 and 1 in 1,000. In contrast, the condition is considered extremely rare in populations without this ancestral background. Because Familial Mediterranean Fever is often misdiagnosed as other inflammatory conditions or appendicitis, global incidence rates are difficult to calculate with certainty. Many cases likely remain undiagnosed or are only identified after a patient develops secondary amyloidosis, a serious complication of untreated inflammation.
Familial Mediterranean Fever affects males and females with relatively equal frequency, though some studies have noted a slight male predominance in certain clinical cohorts. Regarding age of onset, the condition is predominantly pediatric. Statistics indicate that approximately 80% to 90% of individuals with Familial Mediterranean Fever experience their first clinical episode before the age of 20, with many onset cases occurring as early as childhood. While it is rare for the disease to manifest for the first time in adulthood, it is not clinically impossible.
Obtaining precise data for Familial Mediterranean Fever is hampered by several factors, including:
At DiseaseMaps.org, 264 people with Familial Mediterranean Fever have joined our community, providing a valuable real-world perspective on the patient experience. While clinical literature provides the foundational statistics, our community data highlights the lived reality of navigating a chronic, often invisible condition. Connecting with others through platforms like DiseaseMaps allows patients to share insights on symptom management and diagnostic journeys that are often absent from traditional medical textbooks.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.